Russian skater Kamila Valieva, who tested positive for trimetazidine in late December but cleared to continue the Beijing Games, had two other drugs in her body that could be used to treat heart problems, the New York Times said on Tuesday.
The 15-year-old teenager, Russian figure skating prodigy, saw her provisional suspension decided by the Russian anti-doping agency (Rusada) lifted on Monday by the Court of Arbitration for Sport (CAS) without the latter ruling on the merits. of the case.
To discover
The Olympic medal table: Norway already in the lead, France unlocks its counter
Full results of the 2022 Winter Olympics
The complete program of the Beijing Olympics 2022
And this, even if trimetazidine, a molecule used to treat angina pectoris, has been on the World Anti-Doping Agency's prohibited list since 2014, because it would promote blood circulation.
However, according to documents presented to the CAS on Sunday, obtained by the New York Times, the Stockholm laboratory which examined Valieva's sample also found traces of two other heart medications, l hypoxene and L-Carnitine, which are not on the list of prohibited substances.
Earlier in the day on Tuesday, a member of the executive committee of the International Olympic Committee explained that “the argument (of his defense) advanced the contamination with a product that his grandfather took”.
Russian media reported that Valieva drank from the same glass as her grandfather, who takes trimetazidine for a heart problem.
According to the NYT, the latter in a pre-recorded video message claimed during the February 9 hearing with Rusada officials was taking trimetazidine to treat “attacks,” showing a packet of the drug in his possession.
Valieva's mother, claiming that Valieva's grandfather accompanied her daily to training, told CAS that her daughter was taking hypoxene due to "cardiac arrhythmias", reports the New York daily again. .
Authorized to continue the competition at the Games, the one who has already won the team competition, finished at the top of the short program on Tuesday.